Exelon Corp (EXC) · Aug 25, 2026 · Exec change
Executive transition — COO Michael Innocenzo departing in 2027; finance roles filled internally
Exelon promotes internal finance leaders and announces a 2027 COO exit, but leaves earnings guidance and long-term growth targets unchanged.
The real surprise is the planned departure of a senior operating leader. Michael Innocenzo will leave his Exelon COO, PECO CEO, and ComEd chair roles in 2027 on a date not yet set, making this a genuine new leadership event rather than a routine confirmation. 〔0〕
The succession plan is internally sourced, which limits immediate execution disruption but leaves the most important appointment unresolved. Jeanne Jones will add corporate strategy, Robert Kleczynski will become Exelon CFO, Caroline Fulginiti will become controller, and Andrew Plenge will take over as ComEd CFO; however, the filing does not name Innocenzo’s successor or explain why he is leaving. 〔1〕
The earnings framework is unchanged, so this filing does not improve the operating outlook. Exelon reaffirmed its 2026 adjusted operating earnings range of $2.81-$2.91 per share and its expectation that 2025-2029 annualized growth will land near the top of the 5%-7% range.
| Measure | Filing position | Expectation read |
|---|---|---|
| 2026 adjusted operating earnings | $2.81-$2.91 per share (Guidance) | Reaffirmed; no change |
| 2025-2029 annualized adjusted earnings growth | Near top of 5%-7% range (Guidance) | Reaffirmed; no upgrade |
Net: a mixed executive event, not an earnings catalyst. The internal promotions provide continuity and the company maintained its previously communicated targets, but the unexpected departure of the COO/PECO chief and the absence of a named successor add leadership uncertainty. Because the guidance had already been reaffirmed with second-quarter results and sits around a published consensus midpoint of roughly $2.86 per share, the outlook portion is best viewed as priced in rather than a fresh positive signal.
Internal leadership changes take effect October 5, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!